Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Horwitz

Showing results (111-120 of 209) with videos related to

Pageof 21
Sort By:
Haematologica|December 22, 2018
Mogamulizumab <i>versus</i> investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphomaAdrienne A Phillips, Paul A Fields, Olivier Hermine, et al.
Blood|June 28, 2019
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmarkJustin Taylor, Michael Haddadin, Vivek A Upadhyay, et al.
Leukemia & Lymphoma|March 29, 2021
Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experienceZachary D Epstein-Peterson, Nivetha Ganesan, Juliet N Barker, et al.
Blood|July 22, 2021
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell ProjectRanjana H Advani, Tetiana Skrypets, Monica Civallero, et al.
Blood Advances|July 17, 2025
Novel Devimistat Results in Complete Remissions in Heavily Pre-Treated Burkitt Lymphoma in a phase II trialRaphael E Steiner, Liana Nikolaenko, Ranjit Nair, et al.
Plastic and Reconstructive Surgery|February 27, 2024
American Association of Plastic Surgeons Consensus on Breast Implant-Associated Anaplastic Large-Cell LymphomaMark W Clemens, Terence M Myckatyn, Arianna Di Napoli, et al.
Blood|December 14, 2017
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphomaSteven M Horwitz, Raphael Koch, Pierluigi Porcu, et al.
Blood Advances|May 10, 2023
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project NetworkGreg Hapgood, Monica Civallero, Yana Stepanishyna, et al.
Haematologica|March 31, 2018
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell ProjectMonica Bellei, Francine M Foss, Andrei R Shustov, et al.
Aesthetic Surgery Journal|May 31, 2022
2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCLFabio Santanelli di Pompeo, Mark W Clemens, Michael Atlan, et al.
Pageof 21

Showing results (111-120 of 209) with videos related to

Sort By:
Pageof 21
Haematologica|December 22, 2018
Mogamulizumab <i>versus</i> investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphomaAdrienne A Phillips, Paul A Fields, Olivier Hermine, et al.
Blood|June 28, 2019
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmarkJustin Taylor, Michael Haddadin, Vivek A Upadhyay, et al.
Leukemia & Lymphoma|March 29, 2021
Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experienceZachary D Epstein-Peterson, Nivetha Ganesan, Juliet N Barker, et al.
Blood|July 22, 2021
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell ProjectRanjana H Advani, Tetiana Skrypets, Monica Civallero, et al.
Blood Advances|July 17, 2025
Novel Devimistat Results in Complete Remissions in Heavily Pre-Treated Burkitt Lymphoma in a phase II trialRaphael E Steiner, Liana Nikolaenko, Ranjit Nair, et al.
Plastic and Reconstructive Surgery|February 27, 2024
American Association of Plastic Surgeons Consensus on Breast Implant-Associated Anaplastic Large-Cell LymphomaMark W Clemens, Terence M Myckatyn, Arianna Di Napoli, et al.
Blood|December 14, 2017
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphomaSteven M Horwitz, Raphael Koch, Pierluigi Porcu, et al.
Blood Advances|May 10, 2023
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project NetworkGreg Hapgood, Monica Civallero, Yana Stepanishyna, et al.
Haematologica|March 31, 2018
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell ProjectMonica Bellei, Francine M Foss, Andrei R Shustov, et al.
Aesthetic Surgery Journal|May 31, 2022
2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCLFabio Santanelli di Pompeo, Mark W Clemens, Michael Atlan, et al.
Pageof 21